The EEF2K Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population disrupting the eukaryotic elongation factor 2 kinase (EEF2K) gene in HT29 colorectal adenocarcinoma cells. This pooled format provides a heterogeneous loss-of-function model without clonal selection, making it ideal for studies requiring genetic diversity. The polyclonal population captures diverse editing events, offering a physiologically relevant tool to investigate EEF2K-dependent translational control mechanisms.
The HT29 cell line originates from a primary colorectal adenocarcinoma in a 44-year-old female and serves as a well-established epithelial model for intestinal biology. These adherent cells retain key features of intestinal differentiation, including mucin production, and are widely used in drug absorption, metabolism, and colorectal cancer research. Their characterized signaling pathways and genetic tractability make HT29 an optimal host for examining protein synthesis regulation in oncogenic contexts.
EEF2K functions as a critical negative regulator of translation elongation by phosphorylating and inactivating eukaryotic elongation factor 2 (EEF2), thereby reducing global protein synthesis in response to cellular stress. The kinase integrates signals from energy-sensing pathways: it is activated by AMPK under low ATP/AMP ratios and is phosphorylated by mTORC1/S6K1 under nutrient-rich conditions, linking its activity to metabolic status. Calcium/calmodulin binding also directly stimulates EEF2K, while p38 MAPK and PKA provide additional regulatory inputs. Downstream, EEF2K-mediated phosphorylation of EEF2 at Thr56 arrests ribosome translocation, selectively modulating the translation of specific mRNAs involved in proliferation and survival. This regulatory node is further modulated by interactions with HSP90 and dephosphorylation by protein phosphatase 2A (PP2A), embedding EEF2K within a dynamic signaling network that balances protein synthesis with cellular energy homeostasis.
In the HT29 colorectal adenocarcinoma context, EEF2K loss-of-function is particularly relevant for unraveling its role in cancer cell adaptation to nutrient deprivation and therapeutic stress. Colorectal tumors often exhibit heightened protein synthesis demands, and EEF2K-mediated translation control may influence tumor growth, survival, and drug sensitivity. By disrupting EEF2K expression in this intestinal epithelial model, researchers can directly assess how the absence of this kinase impacts proliferation, migration, and metabolic reprogramming under conditions mimicking the tumor microenvironment. This polyclonal knockout pool facilitates robust analysis of EEF2K-dependent phenotypes without the confounding effects of clonal variation, making it a powerful tool for functional genomics studies in colorectal cancer biology.
This knockout model supports a broad range of research applications, including investigation of EEF2K??s role in translational control, evaluation of novel EEF2K inhibitors, and dissection of the integrated stress response in colorectal cancer. Representative assays include Western blotting for EEF2K and phospho-EEF2 to confirm target disruption, RT-qPCR for mRNA quantification, cell proliferation and colony formation assays, migration/invasion analyses, and drug sensitivity screens. Advanced functional studies such as polysome profiling and Seahorse metabolic flux analysis can be employed to examine translation elongation rates and bioenergetic consequences of EEF2K loss. For additional details or custom ordering, please contact Ascent Research.
